Full-Time

Quality Associate Director

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Doctorate degree and 3 years of leading teams focused on the application of emerging technologies to Quality systems
  • Master’s degree and 10 to 14 years of leading teams focused on the application of emerging technologies to Quality systems
  • Bachelor’s degree and 14 to 16 years of leading teams focused on the application of emerging technologies to Quality systems
  • Diploma and 18 to 20 years of leading teams focused on the application of emerging technologies to Quality systems
Responsibilities
  • Support the Quality vision and mission for the Center aligned with Amgen’s mission to serve patients.
  • Support Amgen Site Quality Head in the development and implementation of a multi-year Quality technology roadmap aligned with Amgen’s standards and overall strategic imperatives.
  • Ensure applicable activities align with GxP regulatory requirements, promoting execution excellence and a strong Quality culture.
  • Collaborate with local and global partners to ensure Amgen India future regulatory inspection readiness.
  • Deliver Quality service level agreements with other Amgen sites and key collaborators.
  • Partner with cross-functional digital and technology teams and serve as a Quality point of contact to develop and establish core Amgen India technological capabilities focusing on Artificial Intelligence.
  • Leverage emerging technologies, such as artificial intelligence, to enhance Quality systems, regulatory compliance and drive operational efficiencies.
  • Attract and recruit top talent aligned with the overall Quality organization hiring plan.
  • Develop talent, motivate the team, delegate effectively, champion diversity within the team and act as a role model of Amgen’s Leadership Attributes.
  • Responsible for managing, growing, and developing a core digital technologies team in India, ensuring global ways of working are imbedded in the local organization.
  • Develop and deliver team goals aligned with Amgen Quality & Corporate goals.
  • Oversee unit expenditures and manage budget to ensure adherence to financial targets.
Desired Qualifications
  • A consistent record of prior experience leading teams focused on the application of emerging technologies to Quality systems.
  • 10+ experience in leadership roles in the pharmaceutical industry.
  • PhD, MS or BS in life sciences or Engineering degree preferably in Computer Science/Artificial Intelligence.
  • Demonstrated ability to drive and contribute to large digital transformation programs and collaborate seamlessly with cross-functional matrixed teams.
  • Demonstrated expertise in the application of digital technologies (including AI) to Quality operations.
  • Experience in digital application lifecycle management, and Agile development methodologies.
  • Experience in people management and passion for mentorship, culture and fostering the development of talent.
  • Strong experience in Quality Management Systems oversight and implementation.
  • Ability to lead change management and transformation of a Quality function.
  • In depth knowledge on the application of emerging technologies to global GxP regulations impacting quality activities in the pharmaceutical industry.
  • Excellent verbal and written communication skills/writing skills; active listening skills; attention to detail. Strong process/business writing skills.
  • Ability to translate business and key collaborator feedback into accurate and efficient processes using unambiguous language and format.
  • Strong analytical/critical-thinking and decision-making abilities.
  • Must be flexible and able to manage multiple activities and priorities with minimal direction in a rapidly changing and demanding environment.
  • Fluency in English (written and spoken).
  • Ability to embody the Amgen leadership attributes which are: Inspire, Accelerate, Integrate, Adapt.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.